1 August 2025
Ropes & Gray Advised Bain Capital on Creation of a New Company Dedicated to Developing Innovative Immunology Therapies
Advising firms
Deal team
9 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Abigail Gregor Lead | Ropes & Gray | Partner | life sciences licensing | Not stated |
| Ray Grant Lead | Ropes & Gray | Counsel | life sciences transactions | Not stated |
| Evan Tallmadge | Ropes & Gray | Associate | life sciences licensing | Not stated |
| Arthur Mok | Ropes & Gray | Partner | life sciences transactions | Not stated |
| Bill Mone | Ropes & Gray | Partner | private equity | Not stated |
| Pamela Glazier | Ropes & Gray | Partner | tax | Not stated |
| Kyle Higley | Ropes & Gray | Partner | executive compensation & employee benefits | Not stated |
| Megan Bisk | Ropes & Gray | Partner | executive compensation & employee benefits | Not stated |
| Lisa Kaltenbrunner | Ropes & Gray | Partner | antitrust | Not stated |
6 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 300m ($300 million)
- What the figure measures
- Facility amount
- Client
- Bain CapitalInvestor
- Counterparties
- Bristol Myers Squibb (Other)